Global Engage is pleased to announce as part of their successful Genomic series of events the Synthetic Biology Congress, which will be held on October 20-21 in London, UK and will be co-located with our 2nd Annual qPCR and Digital PCR Congress.

This event will attract over 150 industry & academic experts working in areas such as synthetic biology, bioengineering, biochemical / metabolic / chemical / genetic engineering, systems biology, microbiology, computational / molecular biology, chemistry, mathematics, computing, biochemistry, drug discovery and plant science. This will examine the latest strategies, developments and case studies using synthetic biology to further research in healthcare and the agriculture sectors.  The congress will also have a dedicated section focusing on finance, aimed at those looking for investment opportunities and those seeking funding to exploit their research.

Predicted to be worth $10.8bn globally in 2016, synthetic biology is a fast-growing research area making tremendous scientific, technological and economical impacts worldwide.  The conference will therefore provide a timely interactive networking forum offering the opportunity to take home cutting edge research, strategies, methods and solutions to allow you to keep up to date with the latest advancements, novel methods and applications of Synthetic Biology within your field.

This will be achieved through a vibrant exhibition room full of technology providers showcasing their technologies and other solutions, poster presentation sessions, expert led case study presentations and interactive Q&A panel discussions from a 40 strong speaker faculty examining topics on:

Healthcare / Drug Discovery
Plant Synthetic Biology
Investment, Funding and Bioethics

congress.jpg